Literature DB >> 31750134

Relook on Mastoid Cavity Obliteration: A Prospective Study.

Chiranjib Das1,2, Tapan Kanti Hazra3.   

Abstract

Canal wall down (CWD) mastoidectomy is the operation of choice for unsafe variety of chronic otitis media. But open mastoid cavity poses many problems. The solution of these problems is obliteration of mastoid cavity that is self-cleaning and easily maintained. In our study we aim to establish the effective technique for mastoid cavity obliteration in CWD mastoidectomy and review its efficacy in producing a dry, low maintenance cavity. This was a non-randomized longitudinal prospective study, performed over 2½ years in the department of ENT in a tertiary care hospital of Kolkata. Patients of chronic otitis media unsafe variety within the age group of 16-60 years were included in our study. Chronic otitis media unsafe variety with intratemporal or intracranial complications, and extensive cholesteatoma or granulation tissue that can't be cleared completely during operation were excluded. There was no statistical significance for hearing improvement between CWD mastoidectomy without obliteration and CWD mastoidectomy with obliteration. There was significant statistical significance for obliteration of cavity, epithelized cavity and dry cavity between CWD mastoidectomy without obliteration and CWD mastoidectomy with obliteration. Persistent discharge and granulation were significantly more in non-obliterated group. The time taken by the ear to become dry is much shorter after mastoid cavity obliteration. Moreover, lifelong aural toilet and dependence on an ENT surgeon is avoided. Inspite of all these, a few pre-conditions must be fulfilled before embarking on this type of surgery. © Association of Otolaryngologists of India 2017.

Entities:  

Keywords:  Bone patte; Canal wall down mastoidectomy; Chronic otitis media; Mastoid cavity obliteration; Temporalis muscle pedicle graft

Year:  2017        PMID: 31750134      PMCID: PMC6841815          DOI: 10.1007/s12070-017-1198-y

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  12 in total

1.  Experience with pedicled temporal muscle flaps in radical mastoid and tympanoplasty operations.

Authors:  I B THORBURN
Journal:  J Laryngol Otol       Date:  1961-10       Impact factor: 1.469

2.  The problem of the mastoid segment after tympanoplasty.

Authors:  P H BEALES
Journal:  J Laryngol Otol       Date:  1959-08       Impact factor: 1.469

3.  Mastoid obliteration with the temporoparietal fascia flap.

Authors:  C A East; M D Brough; H R Grant
Journal:  J Laryngol Otol       Date:  1991-06       Impact factor: 1.469

4.  Obliteration of the persistently discharging mastoid cavity using the middle temporal artery flap.

Authors:  Vivian Singh; Marcus Atlas
Journal:  Otolaryngol Head Neck Surg       Date:  2007-09       Impact factor: 3.497

5.  Radical mastoido-epitympanectomy with tympanoplasty and partial obliteration: a new surgical procedure?

Authors:  U Fisch; S Schmid
Journal:  Ann Acad Med Singapore       Date:  1991-09       Impact factor: 2.473

6.  Reconstruction of ear canal in surgery for chronic ear.

Authors:  T PALVA
Journal:  Arch Otolaryngol       Date:  1962-04

7.  [Reduction of radical cavities by homologous cartilage chips].

Authors:  H Decher
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1985-08

8.  Surgical management of the discharging mastoid cavity.

Authors:  R P Mills
Journal:  J Laryngol Otol Suppl       Date:  1988

9.  Late results of obliterative cholesteatoma surgery.

Authors:  K Ojala; A Palva
Journal:  Arch Otolaryngol       Date:  1982-01

10.  Postauricular periosteal-pericranial flap for mastoid obliteration and canal wall down tympanomastoidectomy.

Authors:  Mitchell J Ramsey; Saumil N Merchant; Michael J McKenna
Journal:  Otol Neurotol       Date:  2004-11       Impact factor: 2.311

View more
  1 in total

Review 1.  Pneumatization Pattern and Status of the Mastoid Antrum in Chronic Otitis Media: A Review.

Authors:  Farhat Q Khan; Prasad T Deshmukh; Sagar S Gaurkar
Journal:  Cureus       Date:  2022-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.